INS and Hypoglycemia: Likewise, Taleb et al. (2016) evaluated the performance of a dual-hormone artificial pancreas during a controlled exercise challenge and found that it eliminated hypoglycaemia, compared to an 11% time-in-hypoglycaemia observed with standard insulin therapy [44].